ネブラスカ州における前立腺がんの臨床試験
ネブラスカ州内の拠点で、前立腺がんに関する27件の研究が参加者を募集しています。
ネブラスカ州内の都市
公式研究テキスト（英語）
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- CHI Health Saint Francis, Grand Island
- CHI Health Good Samaritan, Kearney
- Alegent Health Immanuel Medical Center, Omaha
- 他2件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Nebraska Medicine-Bellevue, Bellevue
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Urology Cancer Center, PC, Omaha
被験者募集中第1/2相
18歳以上 · 男性 · 2026/09/25更新 · NCT06800313A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0026), Omaha
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06136650Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Nebraska Cancer Specialists, Omaha
被験者募集中第2/3相
18歳〜100歳 · 男性 · 2026/09/22更新 · NCT06780670Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Nebraska Cancer Specialists, Omaha
被験者募集中第3相
18歳〜100歳 · 男性 · 2026/09/22更新 · NCT06855277PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
- University of Nebraska Medical Center, Omaha
被験者募集中第2相
30歳以上 · 男性 · 2026/09/21更新 · NCT07234981A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- XCancer, Omaha
被験者募集中第1相
18歳以上 · 男性 · 2026/09/15更新 · NCT07581184Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- XCancer Omaha LLC, Omaha
被験者募集中第3相
18歳以上 · 男性 · 2026/09/11更新 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Nebraska Medicine-Bellevue, Bellevue
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
被験者募集中第3相
18歳以上 · 男性 · 2026/09/10更新 · NCT05946213Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, Omaha
被験者募集中第1/2相
18歳〜99歳 · 男性 · 2026/08/27更新 · NCT07590934AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Omaha
被験者募集中第3相
18歳以上 · 男性 · 2026/08/26更新 · NCT07611110Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- XCancer Omaha, Omaha
被験者募集中第2相
18歳以上 · 男性 · 2026/08/24更新 · NCT07745361A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Nebraska Cancer Specialists, Omaha
被験者募集中第1/2相
18歳以上 · 男性 · 2026/08/20更新 · NCT06785636Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- CHI Health Good Samaritan, Kearney
- Alegent Health Bergan Mercy Medical Center, Omaha
被験者募集中第3相
18歳以上 · 男性 · 2026/08/19更新 · NCT04423211Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
- University of Nebraska Medical Center, Omaha
被験者募集中第2相
30歳以上 · 男性 · 2026/08/19更新 · NCT07237269Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- CHI Health Saint Francis, Grand Island
- CHI Health Good Samaritan, Kearney
- Alegent Health Immanuel Medical Center, Omaha
- 他2件
被験者募集中第3相
18歳以上 · 男性 · 2026/07/14更新 · NCT06592924Integrated Cancer Repository for Cancer Research
- Mary Lanning Healthcare, Morrison Cancer Center, Hastings
- Faith Regional Health Services, Carson Cancer Center, Norfolk
- Great Plains Regional Medical Center, North Platte
- 他3件
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Nebraska Cancer Specialists (Midwest Cancer Center - Legacy), Omaha
- XCancer Omaha / Urology Cancer Center, Omaha
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/11更新 · NCT05283330Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Urology Cancer Center PC, Omaha
- Nebraska Cancer Specialists, Omaha
被験者募集中第4相
18歳〜100歳 · 男性 · 2026/06/04更新 · NCT05803941Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
- XCancer Omaha / Urology Cancer Center, Omaha
被験者募集中第1/2相
18歳以上 · 男性 · 2026/05/14更新 · NCT05413850A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Research Site, Omaha
被験者募集中第1相
18歳以上 · 男性 · 2026/05/12更新 · NCT06879041Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- CHI Health Good Samaritan, Kearney
- Saint Elizabeth Regional Medical Center, Lincoln
- Alegent Health Immanuel Medical Center, Omaha
- 他4件
被験者募集中第2相
18歳以上 · 男性 · 2026/01/29更新 · NCT05806515Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Nebraska Medicine-Bellevue, Bellevue
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
被験者募集中第3相
18歳以上 · 男性 · 2026/01/22更新 · NCT06470243High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer
- University of Nebraska Medical Center, Omaha
被験者募集中
19歳以上 · 男性 · 2025/11/05更新 · NCT05754580SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Omaha
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Nebraska Medicine-Bellevue, Bellevue
- Nebraska Methodist Hospital, Omaha
- Nebraska Medicine-Village Pointe, Omaha
- 他1件
被験者募集中第3相
18歳以上 · 男性 · 2025/09/11更新 · NCT03678025ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。